Weill Cornell Medicine investigators have uncovered a way to unleash in blood vessels the protective effects of a type of fat-related molecule known as a sphingolipid, suggesting a promising new strategy for the treatment of coronary artery disease.
The transition to menopause is marked by a progressively higher density of estrogen receptors on brain cells, a measure that remains elevated in women up to their mid-60s, according to a new brain imaging study.
Male breast cancer has distinct alterations in the tumor genome that may suggest potential treatment targets, according to a study by Weill Cornell Medicine investigators.
Dr. Myles Wolf will lead the institutions’ largest clinical and academic department, overseeing 16 divisions and nearly 2,250 physicians and scientists.
Summer Session, part of Cornell’s School of Continuing Education, is open to Cornell students, students from other universities and adult learners who wish to earn up to 15 credits.
An artificial intelligence-powered method for detecting tumor DNA in blood has the potential to improve cancer care with the very early detection of recurrence and close monitoring of tumor response during therapy.
Professors Dr. Silvia Formenti and Dr. Massimo Loda have been elected to the National Academy of Medicine, in recognition of outstanding professional achievement and major contributions to the advancement of the medical sciences.
The ILR School’s Climate Jobs Institute will share its new report, “Building an Equitable, Diverse and Unionized Clean Energy Economy: What We Can Learn from Apprenticeship Readiness,” at an in-person and online event on Nov. 30.
Twelve undergraduates, all ILR majors, took part in the first High Roads Fellowship program to take place in New York City. During the nine-week session, the fellows gained work experience assisting organizations in the NYC region.
The warming of lakes in the Adirondacks, the death of long-time benefactor and alumnus Ratan Tata ’59, B.Arch. ’62, and the retirement of Martha E. Pollack as president were among the most-viewed Chronicle stories of 2024.